Find News

Filter articles

Applied Filters

Showing 51 to 60 of 225 results

Takeda makes waves with neurological collaboration

Japan, US23-02-2018

Japan-based Takeda Pharmaceuticals has entered into a global strategic collaboration with Wave Life Sciences.

UK agrees £500m of life sciences deals in China

China, UK21-02-2018

More than £500 million worth of life sciences and healthcare agreements were signed between the UK and China during the UK Prime Minister’s visit to China earlier this month.

Astellas Pharma expands portfolio by acquiring Universal Cells

Japan, US16-02-2018

Japan-based Astellas Pharma has acquired US-based Universal Cells in a move that will allow it to develop universal donor cell technology.

Sumitomo sues over antipsychotic drug

India, Japan, US14-02-2018

Japan-based Sumitomo Dainippon Pharma has taken on Indian generics company Emcure Pharmaceuticals over an antipsychotic drug.

General Court dismisses Novartis trademark appeal

South Korea, Switzerland01-02-2018

The European General Court dismissed an appeal from Novartis over one of its figurative trademarks yesterday, January 31.

Abe & Partners makes two promotions


Japan-based Abe & Partners has promoted Michiko Kinoshita as partner and Tomohiro Kazama as counsel.

Sandoz enters into biosimilar partnership with Biocon

Germany, India, International22-01-2018

Germany-based Sandoz has entered into a partnership with Biocon to develop, manufacture and commercialise biosimilars in immunology and oncology.

MSF challenges Gilead patent application in China


Médecins Sans Frontières has challenged a patent application filed by Gilead in China, claiming that the rejection of the patent would “pave the way towards the availability of affordable generic versions”. 

AstraZeneca forms Chinese company to boost innovation


AstraZeneca and the Chinese Future Industry Investment Fund have partnered to establish a company focused on discovering, developing and commercialising new medicines.

Sanofi leads the way for gene therapy patents: report


CPA Global has found that Sanofi files the most patents covering human gene therapy and also spends the most on them overall.

Showing 51 to 60 of 225 results